Literature DB >> 21600874

Steatosis induced by the accumulation of apolipoprotein A-I and elevated ROS levels in H-ras12V transgenic mice contributes to hepatic lesions.

Ai-Guo Wang1, Hyung-Bae Moon, Jung-Il Chae, Jin-Man Kim, Ye-Eun Kim, Dae-Yeul Yu, Dong-Seok Lee.   

Abstract

Hepatic steatosis is considered to have an important impact on liver tumorigenesis, despite a lack of clear experimental evidence. Histopathological analysis of H-ras12V transgenic mice showed liver lesions on a steatosis background had significantly higher incidence than on a non-steatosis background. Further investigation showed that apolipoprotein A-I was elevated and accumulated around fatty vacuoles. This elevated level of apolipoprotein A-I was coupled with an elevated level of H-ras12V protein and ROS. In conclusion, our results suggest that the expression of H-ras12V oncogene leads to elevated levels of ROS and apolipoprotein A-I that contribute to steatosis. The steatosis, in turn, promotes the development of hepatic lesions induced by H-ras12V oncogene.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600874     DOI: 10.1016/j.bbrc.2011.05.039

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Essential roles of FoxM1 in Ras-induced liver cancer progression and in cancer cells with stem cell features.

Authors:  Dragana Kopanja; Akshay Pandey; Megan Kiefer; Zebin Wang; Neha Chandan; Janai R Carr; Roberta Franks; Dae-Yeul Yu; Grace Guzman; Ajay Maker; Pradip Raychaudhuri
Journal:  J Hepatol       Date:  2015-03-28       Impact factor: 25.083

2.  Differential Proteomic Analysis of Gender-dependent Hepatic Tumorigenesis in Hras12V Transgenic Mice.

Authors:  Zhuona Rong; Tingting Fan; Huiling Li; Juan Li; Kangwei Wang; Xinxin Wang; Jianyi Dong; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Mol Cell Proteomics       Date:  2017-05-16       Impact factor: 5.911

3.  Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.

Authors:  Y-H Park; S-U Kim; T-H Kwon; J-M Kim; I-S Song; H-J Shin; B-K Lee; D-H Bang; S-J Lee; D-S Lee; K-T Chang; B-Y Kim; D-Y Yu
Journal:  Oncogene       Date:  2015-10-26       Impact factor: 9.867

4.  Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice.

Authors:  Eleni A Karavia; Dionysios J Papachristou; Kassiani Liopeta; Irene-Eva Triantaphyllidou; Odyssefs Dimitrakopoulos; Kyriakos E Kypreos
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

5.  Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice.

Authors:  Tingting Fan; Zhuona Rong; Jianyi Dong; Juan Li; Kangwei Wang; Xinxin Wang; Huiling Li; Jun Chen; Fujin Wang; Jingyu Wang; Aiguo Wang
Journal:  Cancer Med       Date:  2017-09-21       Impact factor: 4.452

6.  Role of the Mitochondrial Citrate-malate Shuttle in Hras12V-Induced Hepatocarcinogenesis: A Metabolomics-Based Analysis.

Authors:  Chuanyi Lei; Jun Chen; Huiling Li; Tingting Fan; Xu Zheng; Hong Wang; Nan Zhang; Yang Liu; Xiaoqin Luo; Jingyu Wang; Aiguo Wang
Journal:  Metabolites       Date:  2020-05-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.